DICE

2.03% -0.4989

시간 외 거래: 24.13 0.0486 +0.20%

Dice Therapeutics Inc (DICE)

개요 뉴스 가격 이력 토론 예측

Relative Volume:

Dice Therapeutics Inc Stock (DICE) Company Profile

Dice Therapeutics Inc

Healthcare (1064)

Biotechnology (595)

650-566-1402

279 East Grand Avenue, Suite 300 Lobby B, South San Francisco

최신 SEC 제출 서류

DICE's Discussions on Twitter

Compare DICE vs VRTX, MRNA, REGN, ARGX, RVMD

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
DICE Dice Therapeutics Inc	24.08	2.27B	0	-104.24M	-87.22M	-2.34
VRTX Vertex Pharmaceuticals Inc	504.73	133.37B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	190.01	79.40B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	735.20	81.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.21	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	206.64	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Dice Therapeutics Inc Stock (DICE) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-03-31	개시	Needham	Buy
2023-03-01	개시	Cowen	Outperform
2023-03-01	개시	TD Cowen	Outperform
2022-11-15	개시	Guggenheim	Buy
2022-09-14	개시	Cantor Fitzgerald	Overweight
2022-09-07	개시	Stifel	Buy
2022-07-18	개시	H.C. Wainwright	Buy
2021-10-11	개시	BofA Securities	Buy
2021-10-11	개시	Evercore ISI	Outperform
2021-10-11	개시	SVB Leerink	Outperform

Dice Therapeutics Inc 주식(DICE)의 최신 뉴스

Dice Therapeutics Inc (DICE) 재무 분석

Dice Therapeutics Inc (DICE)

Dice Therapeutics Inc Stock (DICE) Company Profile

Compare DICE vs VRTX, MRNA, REGN, ARGX, RVMD

Dice Therapeutics Inc Stock (DICE) Upgrades & Downgrades

Dice Therapeutics Inc 주식(DICE)의 최신 뉴스

Talawar Therapeutics Appoints Industry Veterans Mittie Doyle, MD, and Susannah Gray to Board of Directors - PR Newswire

InventHelp Inventor Develops New Card and Dice Combination Game (CHK-6005) - Yahoo Finance

Eli Lilly's Immunology Push Builds New Growth Engines Beyond GLP-1s - The Globe and Mail

Tema Launches Trading & Prediction Markets ETF (DICE) - Yahoo Finance

DICE Therapeutics Inc. (DICE) Peer Comparison – Compare with Others - Value Research

DICE Therapeutics Inc. (DICE) Key Financial Ratios – Valuation, Profitability & More - Value Research

Ambros Therapeutics Announces Appointments of John C. Jacobs and Scott Robertson to Board of Directors - The Manila Times

Autoimmune Treatment Market Report Examines Industry Trends, Growth Drivers And Future Outlook - openPR.com

DHI Group (DHX) Stock Sees Fair Value Lift As Analysts Weigh ClearanceJobs And Dice - Yahoo Finance

Segment Overview and Major Growth Areas in the Urokinase Market - openPR.com

DHI Group Inc (DHX) (Q2 2026) Earnings Call Highlights: ClearanceJobs Surges 24% While DICE ... - Yahoo Finance

CAPR Stock Drop: Capricor Therapeutics Clinical Data Leads to 64% Stock Drop and Securities Fraud Class Action for Investors - PR Newswire

Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology - Eli Lilly and Company

MindWare Brings a New Reiner Knizia Game and a Giant Dice Tower to Gen Con 2026 - Yahoo Finance

A 'Made in the USA' Monopoly edition cost twice as much to build — and no US factory could even make the dice - Yahoo Finance

An InventHelp 123Invent Client Develops New Money Themed Dice Game (LBT-9813) - Yahoo Finance

The EU rolls dice by setting unambiguous parameters for Satcos operating in 2GHz - Yahoo Finance

Tech Professionals Find Relevant Roles Faster with Dice’s LLM Connector - Yahoo Finance

Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188% - The Motley Fool

Morningstar Sees SpaceX Worth Half Its IPO Price - thedeepdive.ca

OpenAI Files Confidential S-1 With SEC, Targeting IPO as Soon as Q4 - thedeepdive.ca

SpaceX Cuts IPO Valuation Target to $1.8 Trillion After Investor Feedback - TheDeepDive.ca

TWO DICE SECURES STRATEGIC INVESTMENT FROM OAK VIEW GROUP - Yahoo Finance

The Psoriasis Clinical Trial Pipeline Boom as 90+ Companies are in the Race for Better Treatments | DelveInsight - GlobeNewswire

Russia is about to roll the dice on crypto regulation. Here’s its playbook - Yahoo Finance

Jim Cramer on JetBlue Airways: “It’s a Dice Roll, and I Don’t Like Dice Rolls” - Yahoo Finance

Here Are Friday’s Top Wall Street Analyst Research Calls: Brown-Forman, Chord Energy, Emerson Electric, FuboTV, Genmab, Honeywell, Knight-Swift, Wix.Com, and More - 24/7 Wall St.

EA Slashes Battlefield Headcount In a Pivot to AI - Yahoo Finance

Burnout, layoffs, 'ghost jobs' in Dice's 2026 tech survey - Stock Titan

Muted and missing M&As: JPM deals absent in 2026 - BioWorld News

Baron of Dice Answers the Questions Players Keep Asking - Yahoo Finance

Lilly snaps up Ventyx for $1.2B in pursuit of oral immune drugs - BioPharma Dive

Tenax Therapeutics: How Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing - Seeking Alpha

Boyd Gaming reveals $160M revamp for Par-A-Dice Casino - Yahoo Finance

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes - American Heart Association Journals

Journal of the European Academy of Dermatology and Venereology - Wiley Online Library

Don't Buy Summit Therapeutics Until This Big Thing Happen - The Motley Fool

Here Are Wednesday's Top Wall Street Analyst Research Calls: DHL Group, NetApp, Nutanix, Oracle, Snowflake, Urban Outfitters, Zscaler and More - 247wallst.com

Big pharma drives surge in biopharma job cuts in 2025 - BioWorld News

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - Business Wire

ESMO 2025: Faeth Therapeutics’ Phase 2 DICE Trial Shows 34% Reduction in Risk of Disease Progression with Oral Sapanisertib Plus Chemotherapy - Business Wire

Updated: DICE rolls on as lead oral IL-17 candidate meets proof-of-concept in PhI trial, sending shares higher - Endpoints News

EA May Sell BioWare And DICE Or Close Other Studios, Says Analyst - Yahoo Finance

RNA Therapeutics Market Size to Reach USD 26.13 Billion by 2034 - BioSpace

Interleukin-17 Inhibitors Market to Witness Strong Growth During the Forecast Period (2020-2034) Driven by Expanding Indications and Therapeutic Innovation | DelveInsight - PR Newswire

Formulation specialist Azurity to lay off 75 amid plans to sunset Massachusetts plant - Fierce Pharma

Fever Acquires Ticketing Platform Dice - Yahoo Finance

Forward Therapeutics, the first biotech from Curie.Bio, raises $50M for oral small molecules in immunology - Endpoints News

DHI Group Inc (DHX) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Focus - Yahoo Finance

Dice Therapeutics Stock Price, News & Analysis - Stock Titan

Biopharma restructurings reflect strategy of short-term pain for long-term gains - BioWorld News

Dice Therapeutics Inc (DICE) 재무 분석

매출

순이익

현금흐름

주당 순 이익

DICE과 유사한 종목